Yue Zhao

18PUBLICATIONS
24CO-AUTHORS
Molecular targetsCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jul 20, 2026
LSD1-GLS2 axis drives subtype-specific chemoresistance in pancreatic cancer through glutaminolysis reprogramming.

|Jul 17, 2026
Targeting the CAF-GDF15 axis attenuates AKT-mediated mitochondrial rewiring and chemoradiation resistance in esophageal adenocarcinoma.

|Feb 05, 2026
Mitophagy in pancreatic cancer: mechanistic insights and implications for novel therapeutic strategies.

Zhefang Wang, Zicheng Lyu, Raphael Palmen

|Nov 27, 2025
Impact of Single- Versus Multiple-Type HPV Infections on Cervical Cytological and Histological Abnormalities: The Dominant Oncogenic Potential of HPV16 Single-Type Infections.

Sunhwa Baek, Sebastian Ludwig, Sophie Lee Sievers

|Oct 21, 2025
Targeting oncogenic acetyltransferase NAT10 to overcome anti-PD-1 resistance in nasopharyngeal carcinoma.

Yue Zhao

|Jul 02, 2025
AKR1C3 enhances radioresistance in esophageal adenocarcinoma via inhibiting ferroptosis through suppressing TRIM21-mediated ubiquitination of HSPA5.

Feng Ju, Jialei Weng, Ningbo Fan

Pageof 3

Frequent Collaborators

4 joint publications

Zhefang Wang

3 joint publications

Christiane J Bruns

3 joint publications

Seung-Hun Chon

3 joint publications

Chenghui Zhou